INS and cardiovascular disorder: Most of the 32 metabolites we discovered were novel and regulated coagulation, cytokine release, lipid oxidation, inflammation, cellular toxicity, insulin resistance, urea and malate–aspartate cycle dysregulation, and especially the risk of cardiovascular diseases.